{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T08:47:45Z","timestamp":1649148465718},"reference-count":18,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Bras. Enferm."],"published-print":{"date-parts":[[2013,10]]},"abstract":"<jats:p>Este estudo pretende identificar os fatores relacionados ao \u00f3bito na Influenza Pand\u00eamica A(H1N1) 2009 em pacientes tratados com Oseltamivir. Trata-se de um estudo observacional e retrospectivo, realizado com dados de pacientes que apresentaram diagn\u00f3stico laboratorial da doen\u00e7a. Os dados foram coletados dos formul\u00e1rios de notifica\u00e7\u00e3o da doen\u00e7a, pertencentes a uma base de dados do Minist\u00e9rio da Sa\u00fade. As an\u00e1lises estat\u00edsticas foram realizadas pelos testes de qui-quadrado, t de Student e por regress\u00e3o log\u00edstica, considerando significativos os valores de p&lt;0,05. A maior ocorr\u00eancia de \u00f3bitos foi observada nos pacientes com idade entre 20 e 59 anos, de baixa escolaridade, com a presen\u00e7a de comorbidades, n\u00e3o vacinados, tratados tardiamente e que apresentavam sintomas mais severos da infec\u00e7\u00e3o. A identifica\u00e7\u00e3o de fatores de risco para o \u00f3bito refor\u00e7a a necessidade de preven\u00e7\u00e3o e assist\u00eancia precoce, principalmente na presen\u00e7a de fatores que aumentam a gravidade cl\u00ednica da doen\u00e7a.<\/jats:p>","DOI":"10.1590\/s0034-71672013000500012","type":"journal-article","created":{"date-parts":[[2013,11,9]],"date-time":"2013-11-09T08:36:58Z","timestamp":1383986218000},"page":"715-721","source":"Crossref","is-referenced-by-count":2,"title":["Fatores relacionados ao \u00f3bito pela Influenza Pand\u00eamica A (H1N1) 2009 em pacientes tratados com Oseltamivir"],"prefix":"10.1590","volume":"66","author":[{"given":"Luana","family":"Lenzi","sequence":"first","affiliation":[{"name":"Universidade Federal do Paran\u00e1, Brasil"}]},{"given":"Lineu Roberto da","family":"Silva","sequence":"additional","affiliation":[{"name":"Secretaria de Estado da Sa\u00fade do Paran\u00e1, Brasil"}]},{"given":"\u00c2ngela Maron de","family":"Mello","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Nacional de Sa\u00fade, Brasil"}]},{"given":"M\u00f4nica Holtz Cavichiolo","family":"Grochocki","sequence":"additional","affiliation":[{"name":"Secretaria de Estado da Sa\u00fade do Paran\u00e1, Brasil"}]},{"given":"Roberto","family":"Pontarolo","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1, Brasil"}]}],"member":"530","reference":[{"key":"ref1","series-title":"Pandemic (H1N1) 2009 - update 91"},{"key":"ref2","series-title":"Informe Epidemiol\u00f3gico: Situa\u00e7\u00e3o epidemiol\u00f3gica da Influenza Pand\u00eamica (H1N1) 2009 no mundo e no Brasil, at\u00e9 a Semana Epidemiol\u00f3gica 47 de 2009"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/AAC.01276-08","article-title":"Activity of the oral neuraminidase inhibitor A-322278 against the Oseltamivir-resistant H274Y (A\/H1N1) influenza virus mutant in mice","volume":"53","author":"Baz M","year":"2009","journal-title":"Antimicrob Agents Chemother","ISSN":"http:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0929-6646(09)60369-7","article-title":"Novel swine-origin Influenza virus A (H1N1): the first pandemic of the 21st century","volume":"108","author":"Chang LY","year":"2009","journal-title":"J Formos Med Assoc","ISSN":"http:\/\/id.crossref.org\/issn\/0929-6646","issn-type":"print"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3201\/eid1509.090452","article-title":"Genomic diversity of Oseltamivir-resistant influenza virus A (H1N1), Luxembourg, 2007-08","volume":"15","author":"Gerloff NA","year":"2009","journal-title":"Emerg Infect Dis","ISSN":"http:\/\/id.crossref.org\/issn\/1080-6040","issn-type":"print"},{"issue":"1-2","key":"ref6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1503\/cmaj.090866","article-title":"Safety of neuraminidase inhibitors against novel Influenza A (H1N1) in pregnant and breastfeeding women","volume":"7;181","author":"Tanaka T","year":"2009","journal-title":"CMAJ","ISSN":"http:\/\/id.crossref.org\/issn\/0820-3946","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"ii11","DOI":"10.1093\/jac\/dkq012","article-title":"Oseltamivir in seasonal Influenza: cumulative experience in low- and high-risk patients","volume":"65","author":"Dutkowski R","year":"2010","journal-title":"J Antimicrob Chemother","ISSN":"http:\/\/id.crossref.org\/issn\/0305-7453","issn-type":"print"},{"key":"ref8","series-title":"Protocolo de manejo cl\u00ednico e vigil\u00e2ncia epidemiol\u00f3gica da Influenza"},{"key":"ref9","series-title":"Informe SNVS\/Anvisa\/GFARM n\u00ba , de 1\u00ba de abril de 2010: Oseltamivir no Brasil: uma an\u00e1lise das notifica\u00e7\u00f5es de suspeitas de eventos adversos encaminhadas \u00e0 Anvisa, maio a dezembro de 2009"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"e6051","DOI":"10.1371\/journal.pone.0006051","article-title":"Severe Human Influenza Infections in Thailand: Oseltamivir Treatment and risk factors for fatal outcome","volume":"4","author":"Hanshaoworakul W","year":"2009","journal-title":"PLos ONE"},{"issue":"8","key":"ref11","first-page":"1016","article-title":"Efficacy and safety of the oral neuraminidase inhibitor Oseltamivir in treating acute Influenza: a randomized controlled trial","volume":"283","author":"Treanor JJ","year":"2000","journal-title":"US Oral Neuraminidase Study Group. JAMA"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0300-2896(10)70016-8","article-title":"Influenza A (H1N1): manifestaciones cl\u00ednicas e indicaciones profil\u00e1cticas y terap\u00e9uticas","volume":"46","author":"Huerta Garc\u00eda A","year":"2010","journal-title":"Arch Bronconeumol","ISSN":"http:\/\/id.crossref.org\/issn\/0300-2896","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1471-2334-10-145","article-title":"Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China","volume":"10","author":"Cui W","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"e18221","DOI":"10.1371\/journal.pone.0018221","article-title":"A Review of adult mortality due to 2009 Pandemic (H1N1) Influenza a in California","volume":"6","author":"Louie JK","year":"2011","journal-title":"PLoS One"},{"issue":"49","key":"ref15","doi-asserted-by":"crossref","first-page":"pii: 19741","DOI":"10.2807\/ese.15.49.19741-en","article-title":"Mortality of 2009 pandemic influenza A(H1N1) in Germany","volume":"15","author":"Wilking H","year":"2010","journal-title":"Euro Surveill"},{"issue":"5","key":"ref16","first-page":"547","article-title":"[Critically ill patients with 2009 pandemic influenza A (H1N1) infection in Spain: factors associated with death, April 2009-January 2010]","volume":"84","author":"Santa-Olalla Peralta P","year":"2010","journal-title":"Rev Esp Salud P\u00fablica"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1471-2334-10-211","article-title":"Oseltamivir for treatment and prevention of pandemic influenza A\/H1N1 virus infection in households, Milwaukee, 2009","volume":"10","author":"Goldstein E","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1590\/S0104-11692008000500006","article-title":"Hospital morbidity among elderly patients, before and after Influenza vaccination in the state of Paran\u00e1","volume":"16","author":"Ferrer ALM","year":"2008","journal-title":"Rev Latino-Am Enferm"}],"container-title":["Revista Brasileira de Enfermagem"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/reben\/v66n5\/12.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T05:20:16Z","timestamp":1564636816000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0034-71672013000500012&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0034-71672013000500012"],"URL":"https:\/\/doi.org\/10.1590\/s0034-71672013000500012","relation":{},"ISSN":["0034-7167"],"issn-type":[{"value":"0034-7167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}